Defining the role of panitumumab in colorectal cancer

Ainda não traduzido Ainda não traduzido
Autores
Categoria Primary study
RevistaCommunity oncology
Year 2006
Panitumumab is the first fully human anti‐EGFR monoclonal antibody available for the treatment of advanced colorectal cancer. The drug appears to be well tolerated and has demonstrated antitumor activity and clinical benefit both as a single agent and in combination with cytotoxic chemotherapy.
Epistemonikos ID: 447e859495e179ba8695663795280caee2bb11af
First added on: Feb 01, 2023